About Us
About Agora Open Science Trust
Our Open Science Approach
Our Business Model for Affordable Medicines
Our Programs
Affordable Medicines
Reproducibility in Biomedicine
Policy and Advocacy
Our Team
Board of Directors
Management
Partners
News & Media
In the News
Press Releases
Contact Us
Get Involved

Agora Open Science Trust

About Us
About Agora Open Science Trust
Our Open Science Approach
Our Business Model for Affordable Medicines
Our Programs
Affordable Medicines
Reproducibility in Biomedicine
Policy and Advocacy
Our Team
Board of Directors
Management
Partners
News & Media
In the News
Press Releases
Contact Us
Get Involved
  • News & Media
  • In the News
  • Press Releases

Media Coverage

April 25, 2025: Building a Better Future for Open Drug Discovery: Agora and M4K at the Conscience Symposium 2025

March 24, 2025: Reimagining Drug Development: Moving Beyond Patents

September 7, 2020: When antibodies mislead: the quest for validation

July 20, 2020: Change-makers bring on recombinant antibodies

Apr 11, 2019: Drug development: the researchers driving an open-science approach

Feb 15, 2019: U of T researcher's open science drug discovery model expands to neurodegenerative diseases

Feb 6, 2019: For innovation, open science means open for business

Nov 3, 2017: Making medicine, not money: How one U of T researcher's startup is rethinking Big Pharma's business model

 
Back to Top
Terms of Use
Privacy Policy
Contact Us
Get Involved

Agora Open Science Trust
MaRS South Tower
101 College Street, Suite 700
Toronto, ON M5G 1L7 Canada
info@agoraopensciencetrust.org

Canadian Charitable Registration #81485 1960 RR0001
©Agora Open Science Trust 2024 – CC-BY 4.0